Controlling Lipid Impurities from Raw Materials Through Final Drug Product
- Characterize incoming lipid quality using tandem mass spec and HPLC, identify critical impurities, establish acceptance criteria
- Track impurity profiles through formulation process, understand degradation pathways, implement stability-indicating methods
- Demonstrate component stability in final drug product, meet regulatory expectations, ensure product consistency